Innovita Biological Technology Co. Ltd. A
医疗健康 · 生物科技
Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in research and development, production and sales of POCT rapid diagnostic products. It offers Covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test and TORCH test, neurological testing and hepatitis test, as well as tropical disease test such as neurological testing. The company was founded in 2006 and is based in Beijing, China.
MARKET 市值 7.39B CNY PE 81.7x
52W ¥29.77 – ¥67.99
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY -47.4%
▼ ROE 4.3% 营业利润率 38.0% 净利润率 27.7%
ANALYST 股息率 0.82%